Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-11-15Clinical Trial Update: Psychosocial Study on Breast Cancer Risk Assessment
This clinical trial update reports the completion of a psychosocial study on breast cancer risk assessment conducted by the University Healt…
-
CLINICAL_TRIALS trial_result · 2007-11-14Clinical Trial Update: Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update of continuous temozolomide in patients with advanced or metastatic soft tissue sarcoma or metastatic breast ca…
-
FDA approval · 2007-11-08FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from URONOVA PHARMACEUTICALS, INC., signaling an expanded/updated …
-
CLINICAL_TRIALS research · 2007-11-08Clinical Trial Update: A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy [Phase 1, Phase 2]
This is an update on a Phase 1/2 pilot trial evaluating EW02 for safety and its ability to reduce chemotherapy-induced neutropenia in breast…
-
CLINICAL_TRIALS research · 2007-10-24Clinical Trial Update: Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study [Phase 2]
This document provides an update on a Phase 2 pilot study evaluating dose-dense chemotherapy plus bevacizumab for high-risk lymph node-posit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-10-18Clinical Trial Update: PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) [Phase 3]
This is a Phase 3 completed clinical trial update examining how PET imaging may help assess regional disease in breast cancer.
-
CLINICAL_TRIALS trial_result · 2007-10-17Clinical Trial Update: German Preoperative Adriamycin Docetaxel Study [Phase 2]
Phase 2 preoperative study of Adriamycin (doxorubicin) and docetaxel in breast cancer has completed in Germany.
-
FDA approval · 2007-10-16FDA Approved: IXEMPRA — Original Application (R-Pharm US Operating, LLC)
FDA approved IXEMPRA (ixabepilone) through an original NDA for metastatic or locally advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2007-10-12Clinical Trial Update: Arimidex Observational: Reason for and Effect of Change From Tamoxifen
An observational update on Arimidex (anastrozole) examines why patients were switched from Tamoxifen and the effects of that change in breas…
-
CLINICAL_TRIALS research · 2007-10-04Clinical Trial Update: Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism,in Malignant Breast Diseases
A completed study from Mansoura University examining the influence of the CYP2D6*4 polymorphism on malignant breast diseases.
-
CLINICAL_TRIALS research · 2007-09-27Clinical Trial Update: Dyadic Coping in Breast and Prostate Cancer Patients and Their Spouses
Clinical trial update describing a study on dyadic coping in breast cancer and prostate cancer patients and their spouses; sponsor is Tel-Av…
-
CLINICAL_TRIALS trial_result · 2007-09-20Clinical Trial Update: Effect of Counseling on Psychological Stress Amongst Women Felt to be at High Risk for Breast Cancer Development
A completed clinical trial evaluating whether counseling reduces psychological stress in women at high risk for developing breast cancer.
-
CLINICAL_TRIALS trial_result · 2007-09-12Clinical Trial Update: A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease [Phase 2]
This update reports the completion of a Phase 2 clinical trial for HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2007-09-11Clinical Trial Update: Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System
Clinical trial update on an adjunctive efficacy study of the SoftScan Optical Breast Imaging System in breast cancer.
-
CLINICAL_TRIALS trial_result · 2007-09-10Clinical Trial Update: Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer [Phase 3]
Phase 3 randomized trial comparing atamestane plus toremifene versus letrozole in advanced breast cancer was terminated.
-
CLINICAL_TRIALS research · 2007-09-06Clinical Trial Update: Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma [Phase 4]
Phase 4 trial update investigating whether a single corticosteroid injection reduces the formation of postmastectomy seroma in breast cancer…
-
CLINICAL_TRIALS research · 2007-09-06Clinical Trial Update: Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer [Phase 2, Phase 3]
This document describes a clinical trial evaluating an adjuvant schedule of docetaxel, an anthracycline, and cyclophosphamide for breast can…
-
CLINICAL_TRIALS trial_result · 2007-08-31Clinical Trial Update: A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial assessing gemcitabine plus vinorelbine as first-line chemotherapy for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-23Clinical Trial Update: The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer [Phase 3]
Phase 3 trial comparing atamestane plus toremifene versus letrozole in advanced breast cancer was terminated.
-
FDA approval · 2007-08-20FDA Approved: TYKERB — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for TYKERB (lapatinib) from Novartis Pharmaceuticals Corporation to update its labeling.
-
CLINICAL_TRIALS trial_result · 2007-08-02Clinical Trial Update: An Intervention to Decrease Fatigue Among Breast Cancer Survivors [NA]
A clinical trial evaluating an intervention to decrease fatigue in breast cancer survivors has completed.
-
CLINICAL_TRIALS trial_result · 2007-07-25Clinical Trial Update: Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant chemotherapy with docetaxel, cisplatin, and capecitabine for locally advanced breast cancer. The study …
-
CLINICAL_TRIALS trial_result · 2007-07-20Clinical Trial Update: Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer [Phase 1]
This is a Phase 1 trial evaluating Adriamycin (doxorubicin) plus cyclophosphamide followed by Abraxane as adjuvant therapy for breast cancer…
-
FDA approval · 2007-07-17FDA Approved: EVISTA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for EVISTA (raloxifene hydrochloride) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2007-07-13Clinical Trial Update: Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer [Phase 3]
This entry reports on a Phase 3 clinical trial evaluating vertebroplasty for vertebral metastasis from breast and prostate cancer; the curre…